Inventor
WU GUAILI
CN15 patents
Patents
15 patentsUS10150770B2Dec 11, 2018
Crystal form of bisulfate of JAK inhibitor and preparation method therefor
JIANGSU HENGRUI MEDICINE CO6 citations82
US9422300B2Aug 23, 2016
Bisulfate of janus kinase (JAK) inhibitor and preparation method therefor
JIANGSU HENGRUI MEDICINE CO9 citations82
US10023577B2Jul 17, 2018
Crystalline form of JAK kinase inhibitor bisulfate and a preparation method thereof
JIANGSU HENGRUI MEDICINE CO6 citations81
US9309226B2Apr 12, 2016
Crystalline form I of tyrosine kinase inhibitor dimaleate and preparation methods thereof
JIANGSU HENGRUI MEDICINE CO3 citations72
US10626116B2Apr 21, 2020
Crystalline form of BTK kinase inhibitor and preparation method thereof
JIANGSU HENGRUI MEDICINE CO2 citations71
US10160759B2Dec 25, 2018
Hydroxyethyl sulfonate of cyclin-dependent protein kinase inhibitor, crystalline form thereof and preparation method therefor
JIANGSU HENGRUI MEDICINE CO4 citations70
US10358424B2Jul 23, 2019
Sodium salt of uric acid transporter inhibitor and crystalline form thereof
JIANGSU HENGRUI MEDICINE CO1 citations69
US11059810B2Jul 13, 2021
Pharmaceutically acceptable salt as renal outer medullary potassium channel inhibitor
JIANGSU HENGRUI MEDICINE CO0 citations60
US11198683B2Dec 14, 2021
Method for preparing tyrosine kinase inhibitor and derivative thereof
JIANGSU HENGRUI MEDICINE CO0 citations57
US10030018B2Jul 24, 2018
Hydroxyethyl sulfonate of cyclin-dependent protein kinase inhibitor, crystalline form thereof and preparation method therefor
JIANGSU HENGRUI MEDICINE CO0 citations49
US10196361B2Feb 5, 2019
Sodium salt of uric acid transporter inhibitor and crystalline form thereof
JIANGSU HENGRUI MEDICINE CO0 citations48
US10793548B2Oct 6, 2020
Method for preparing tyrosine kinase inhibitor and derivative thereof
JIANGSU HENGRUI MEDICINE CO0 citations47
US10150739B2Dec 11, 2018
Crystalline form of androgen receptor inhibitor and preparation method thereof
JIANGSU HENGRUI MEDICINE CO0 citations47
US10301344B2May 28, 2019
L-proline complex of sodium-glucose cotransporter 2 inhibitor, monohydrate and crystal form thereof
JIANGSU HENGRUI MEDICINE CO0 citations46
US10118911B2Nov 6, 2018
P-toluenesulfonate for MEK kinase inhibitor, and crystal form thereof and preparation method therefor
JIANGSU HENGRUI MEDICINE CO0 citations46